L-DOPA-d6 is a deuterated form of L-DOPA, which serves as a metabolically stable analog for use in pharmacokinetic and metabolic studies. L-DOPA (Levodopa) is an orally active metabolic precursor of the neurotransmitter dopamine; it crosses the blood-brain barrier and is converted to dopamine in the brain. L-DOPA exhibits anti-hyperalgesic effects and has potential in the research of Parkinson's disease.